Gingicaine Liquid, Cherry
Product Images NDC 10129-720

15 FDA label images from Gingi-pak A Division Of The Belport · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Liquid, Cherry (NDC 10129-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

Keep Out Of Reach Of Children (Children Page 001)
A text panel warning that all Gingicaine Gel products should be kept out of reach of children and instructing to call a doctor immediately if Gingicaine is ingested or swallowed by a child, advising to follow directions accordingly.*
FDA Label Image

Contraindications

Contraindications
This image shows a warning and contraindications section for a product, stating it should not be used in patients with hypersensitivity to ester-type local anesthetics and is not recommended for teething or children under 2 years old.*
FDA Label Image

Gingicaine Cherry Liquid Jar Label

Gingicaine Cherry Liquid Jar Label
Drug Facts panel for GingiCaine Liquid, Cherry, 20% Benzocaine oral anesthetic. The text includes active ingredient, purposes, uses, allergy alert, warnings, directions, dosage & administration, and cautions. Also displayed are manufacturer details, net content of 1 oz (30 grams), product reference number 20100, and NDC 10129-720-03. The label highlights that it is a topical anesthetic made in the USA with cherry flavor.*
FDA Label Image

Inactive Ingredient (Gingicaine Liquid Inactive Ingredient)

Inactive Ingredient (Gingicaine Liquid Inactive Ingredient)
A text panel listing inactive ingredients including Polyethylene Glycol 400 and Potassium Sodium Saccharate. The image appears to be part of an ingredient or formulation section of the drug label for GingiCaine Liquid, Cherry.*
FDA Label Image

Active Ingredient (Gingicaine Active Ingredients 001)

Active Ingredient (Gingicaine Active Ingredients 001)
A drug facts label panel showing the active ingredient Benzocaine at 20% w/v, classified for use as an oral anesthetic.*
FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 001)

Allergy Alert (Gingicaine Allergy Alert 001)
A safety warning panel titled 'Allergy alert' that advises not to use the product if there is a history of allergy to any 'caine' local anesthetics or FD&C Red #40.*
FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)
Text panel excerpt from GingiCaine Liquid, Cherry, warning to avoid excessive heat above 40°C (104°F). The text cautions about temperature limits for product storage or handling.*
FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor)

Consult A Doctor Promptly (Gingicaine Consult A Doctor)
A safety warning panel advising to consult a doctor promptly if symptoms like severe sore throat, fever, headache, rash, nausea, or vomiting occur, or if mouth sore does not go away within 10 days, or if irritation, pain, or redness worsens. It advises avoiding contact with eyes, keeping the product out of reach of children, and seeking medical help if overused or swallowed. It cautions against exceeding recommended dosage.*
FDA Label Image

Dosage And Administration 001 (Gingicaine Dosage And Admin 001)

Dosage And Administration 001 (Gingicaine Dosage And Admin 001)
Text panel providing instructions under the heading 'Dosage & Administration,' advising that mucosa should be dried prior to application and excess saliva removed. The visible content focuses on preparation steps before product use.*
FDA Label Image

Dosage And Administration 002 (Gingicaine Dosage And Admin 002)

Dosage And Administration 002 (Gingicaine Dosage And Admin 002)
Text panel providing usage directions and precautions for GingiCaine Liquid, Cherry anesthetic. It advises applying to affected area with sterile cotton or gauze, avoiding cross-contamination, limiting use to adults and children 2 years and older, not exceeding recommended dosage, and consulting a doctor for children under 2 years.*
FDA Label Image

Indications (Gingicaine Indications 001)

Indications (Gingicaine Indications 001)
Text panel titled 'Indications' describing the use of a product for anesthesia of mucous membranes of the oropharynx. It lists applications including pain minimization for ulcers, needle puncture, deep scaling, matrix band application, and aiding dental impressions or intraoral radiographs in patients with an excessive gag reflex.*
FDA Label Image

Precautions (Gingicaine Precaution 001)

Precautions (Gingicaine Precaution 001)
A cautionary text panel titled Precautions. It advises dentists to avoid application of local anesthetics to severely traumatized mucosal areas or posterior pharynx areas that may suppress protective reflexes. It warns that local anesthetics should be used cautiously in patients with known drug sensitivities, especially allergies to ester-type anesthetics such as procaine, benzocaine, and tetracaine, and to avoid contact with all local anesthetics to prevent possible sensitization.*
FDA Label Image

Uses (Gingicaine Uses 001)

Uses (Gingicaine Uses 001)
A text panel titled 'Uses' listing conditions for pain or discomfort relief including minor dental procedures, minor gum injury, canker sores, sore throat, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*
FDA Label Image

Purpose (Purpose Page 001)

Purpose (Purpose Page 001)
A small text panel stating that Gingicaine Gel is a topical anesthetic used by dentists just prior to an injection, typically applied on a patient's gum.*
FDA Label Image

Warnings

Warnings
A warning text panel for GingiCaine Liquid, Cherry, stating it is for external use only. It warns about the rare but serious risk of methemoglobinemia, listing symptoms such as pale or blue colored skin, headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, and fatigue. It advises to cease use and seek immediate medical attention if symptoms develop. The text also warns not to use in children under 2 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.